Skip to main content
. Author manuscript; available in PMC: 2020 Jun 1.
Published in final edited form as: Mol Cancer Res. 2019 Feb 26;17(6):1351–1364. doi: 10.1158/1541-7786.MCR-18-1068

Figure 7: CPS1 expression is high in LADC and correlated with worse overall patient survival.

Figure 7:

A. Oncomine analysis of CPS1 expression in fetal lung, normal lung, and lung adenocarcinoma. B. Oncomine analysis of CPS1 expression across cancers (Legend in Supplemental Table 5) with LADC highlighted (Group 17). C. High and low CPS1 expression correlated with overall survival probability in LADC patients across all stages. D. High and low CPS1 expression correlated with overall survival probability in LADC patients in stages 1/2. E. High and low CPS1 expression correlated with overall survival probability in LADC patients in stages 3/4. F. Overall survival probability for smoker and never smoker patients with LADC exhibiting high or low CPS1 expression.